Immunex Rhode Island Corporation

Form 483 issued December 7, 2021 · West Greenwich, Rhode Island

Observations
4
Pages
2
FEI number
3003359885

In short: On December 7, 2021, FDA issued a Form 483 with 4 observations to Immunex Rhode Island Corporation in West Greenwich, Rhode Island (FEI 3003359885). The investigators were Jacek Cieslak, Leiyun Boone and Richard Ledwidge. Most observations concern laboratory controls and facilities & equipment; the most-cited regulation is 21 CFR 211.160 (general requirements).

At a glance

Laboratory controls and facilities & equipment account for 3 of 4 observations.

Laboratory controls2
Facilities & equipment1
Other1

Most cited: 21 CFR 211.160 (2×) · 211.68 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Your firm lacks procedural control to ensure that incoming…

  2. 02

    Your cleaning procedures for…

  3. 03

    Facility equipment is not…

  4. 04

    Standard operating procedures are…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Immunex Rhode Island Corporation?

FDA listed 4 observations on this Form 483, mostly about laboratory controls and facilities & equipment. The most-cited regulation is 21 CFR 211.160 (general requirements). The opening words of each observation are shown on this page.

Who inspected Immunex Rhode Island Corporation?

Jacek Cieslak, Leiyun Boone and Richard Ledwidge are named on this Form 483. Each investigator has a profile showing what they cite most.

When was Immunex Rhode Island Corporation inspected by FDA?

This Form 483 is dated December 7, 2021.

How do I get the full Form 483 for Immunex Rhode Island Corporation?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free